(19)
(11) EP 4 288 536 A1

(12)

(43) Date of publication:
13.12.2023 Bulletin 2023/50

(21) Application number: 22700444.7

(22) Date of filing: 18.01.2022
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; C12N 2310/14; C12N 2320/34; C12N 2310/351; C12N 2310/3521; C12N 2310/3525; C12N 2310/3527; C12N 2310/3533; C12N 2310/531; C12N 2310/321; C12N 2310/322; C12N 2310/3231
(86) International application number:
PCT/IB2022/050376
(87) International publication number:
WO 2022/167877 (11.08.2022 Gazette 2022/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 05.02.2021 IT 202100002573

(71) Applicant: Dante Labs S.r.l.
67017 Pizzoli AQ (IT)

(72) Inventor:
  • PAONE, Riccardo
    67100 L'Aquila (IT)

(74) Representative: Antonucci, Alessandra 
Società Italiana Brevetti S.p.A. Piazza di Pietra, 38-39
00186 Roma
00186 Roma (IT)

   


(54) SMALL INTERFERING RNA (SIRNA) FOR THERAPY OF MMIHS CAUSED BY ACTG2 GENE MUTATION